GRHL2 induces liver fibrosis and intestinal mucosal barrier dysfunction in non‐alcoholic fatty liver disease via microRNA‐200 and the MAPK pathway. The gene discussed is GRHL2; the disease is metabolic dysfunction-associated steatotic liver disease.